Gansulog Dosage & Drug Information

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Thai FDA Category Presentation/Packing

Concise Prescribing Info

Contents

Insulin glargine

Indications/Uses

Type 1 & 2 DM in patients ≥18 yr requiring insulin.

Click to view Gansulog detailed prescribing information

Dosage/Direction for Use

SC Patient ≥18 yr Type 1 DM Initially approx ¹/₃-¹/₂ of total daily insulin requirement once daily. Type 2 DM Initially 0.2 u/kg basal insulin once daily up to 10 u daily.

Click to view Gansulog detailed prescribing information

Overdosage

View Gansulog overdosage for action to be taken in the event of an overdose.

Contraindications

Hypersensitivity.

Click to view Gansulog detailed prescribing information

Special Precautions

Discontinue use if hypersensitivity reactions occur. Not intended for IV or IM administration or via insulin pump. Hypoglycemia; hypokalemia. Potential risk of delayed insulin absorption & worsened glycemic control. Monitor blood glucose in insulin clearance metabolism changes & after inj site change. Perform continuous inj site rotation. Concomitant use w/ ethanol. Avoid hypoglycemia whilst driving. May impair ability to drive & use machines. Renal & hepatic impairment. Pregnancy. Patients <18 yr.

Click to view Gansulog detailed prescribing information

Use In Pregnancy & Lactation

Click to view Gansulog detailed prescribing information

Adverse Reactions

HTN, peripheral edema, retinal vascular disease, thrombophlebitis, traumatic haematoma; depression, headache; hypoglycemia, Na retention; diarrhea, nausea, vomiting, toothache; UTI; Ab development; infection, flu; erythema, itching, pain & swelling at inj site, localized edema, extravasation, phlebitis; arthralgia, back & limb pain; cataract retinopathy; bronchitis, cough, nasopharyngitis, pharyngitis & rhinitis (child & adolescents), sinusitis, URTI, oropharyngeal pain; accidental injury, chest pain; lipodystrophy, cutaneous amyloidosis at inj site.

Click to view Gansulog detailed prescribing information

Drug Interactions

Concomitant use w/ macimorelin & pioglitazone. Increased levels/effects of hypoglycemia-associated agents eg, pioglitazone. Increased levels/effects w/ α-lipoic acid, androgens, antidiabetics, β-blockers, dipeptidyl peptidase-IV inhibitors, edetate Ca disodium, edetate disodium, glucagon-like peptide-1 agonists, guanethidine, herbs (hypoglycemic properties), liraglutide, metreleptin, MAOIs, pegvisomant, pioglitazone, pramlintide, prothionamide, quinolones, salicylates, SSRIs, Na-glucose co-transporter 2 inhibitors. Decreased levels/effects of macimorelin. Decreased levels/effects w/ hyperglycemia-associated agents eg, quinolones, ritodrine, thiazide & thiazide-like diuretics.

Click to view Gansulog detailed prescribing information

Caution For Usage

For caution against possible variation of physical aspect of medicine... Click to view Gansulog detailed prescribing information

Storage

View Gansulog storage conditions for details to ensure optimal shelf-life.

Description

View Gansulog description for details of the chemical structure and excipients (inactive components).

Action

View Gansulog mechanism of action for pharmacodynamics and pharmacokinetics details.

MIMS Class

Insulin Preparations

ATC Classification

A10AE04 - insulin glargine ; Belongs to the class of long-acting insulins and analogues for injection. Used in the treatment of diabetes.

Thai FDA Category

Presentation/Packing

Form

Gansulog soln for inj 100 IU/mL

Packing/Price

3 mL x 1's

Gansulog

insulin glargine

Manufacturer:

Gan & Lee

Distributor:

Cosma Medical

Marketer:

Cosma Medical